Molecular receptors enrich methylated and acetylated peptides for ultra-sensitiv...
Molecular receptors enrich methylated and acetylated peptides for ultra-sensitive proteomics to explore the hidden modified proteome in disease
Scientific studies indicate that inefficient epigenetic control is associated with a wide variety of non-communicable diseases (NCDs) like cancer, schizophrenia, and diabetes. Indeed, histone post translational modifications (PTMs...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PRE2020-092083
Genomic, proteomic, transcriptomic alterations in growth con...
99K€
Cerrado
nbPTMs
A multifaceted platform for exploring nucleotide based post...
2M€
Cerrado
SAF2011-22803
EL DNA METILOMA DEL GENOMA TRANSCRITO NO-CODIFICANTE EN CANC...
569K€
Cerrado
ChemProt-HLMS
Chemical proteomics for universal profiling of histone lysin...
222K€
Cerrado
BFU2008-04131
CARACTERIZACION DE RNAS NO CODIFICANTES INVOLCUCRADOS EN EL...
109K€
Cerrado
RTI2018-094049-B-I00
DISRUPCION EPIGENETICA Y GENETICA DE LAS MODIFICACIONES DEL...
Cerrado
Información proyecto ENRICH
Duración del proyecto: 47 meses
Fecha Inicio: 2024-01-01
Fecha Fin: 2027-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Scientific studies indicate that inefficient epigenetic control is associated with a wide variety of non-communicable diseases (NCDs) like cancer, schizophrenia, and diabetes. Indeed, histone post translational modifications (PTMs) are crucial for many cellular processes including transcription and DNA repair. Thus, the ability to readily and reliably detect PTMs is crucial to better understand epigenetic processes and the complex functions of histone PTMs in human diseases. Mass spectrometry (MS) is the technique of choice to identify such modifications across the proteome. MS requires an enrichment step generally performed using antibodies, but these have several limitations such as high costs, batch-to-batch variability and data reproducibility. In a multidisciplinary effort ENRICH aims at developing new cost-effective, fast and efficient tools for the enrichment of post translationally modified proteins overcoming the current limitation. ENRICH will functionalize nanoparticles (NPs) with molecular receptors able to enrich PTM-containing peptides, derived from proteolytic digestion, for subsequent MS analysis. Concurrently, the ability and selectivity of the synthesized receptors and functionalized NPs will be evaluated via spectroscopic analyses. The ENRICH network gathers the expertise required to tackle this challenge. The consortium is composed of 9 high-level academic research groups from 2 different continents (Europe and America) and 2 highly innovative companies. By the seconding of 87 ERs/ERSs across Europe and worldwide, the aim is to capitalize on the consortium expertise in complementary fields such as chemical synthesis, spectroscopy, and proteomics. The network promotes an effective integrate training of researchers, boosting their career development, and promotes collaborations between the partners. The direct involvement of industries guarantees the timely exploitation of the results from research laboratories to innovative products.